Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Relationship between presenting symptoms and tumor location in colorectal cancer patients

Universa Medicina · Vol. 43 No. 3 (2024) · hlm. 321–328

DOI
10.18051/UnivMed.2024.v43.321-328
ISSN
2407-2230, 1907-3062
Terbit
2024-12-09
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

BackgroundColorectal cancer (CRC) often shows symptoms at an advanced stage, causing delayed diagnosis and poorer prognosis. Initial symptoms, or chief complaints, are usually identified through patient history and can vary based on tumor location. This can help in establishing a diagnosis. This study aimed to determine the relationship between presenting symptoms and tumor location in CRC patients at Zainoel Abidin Regional General Hospital, Banda Aceh. Methods This cross-sectional study was conducted using secondary data from medical records (2019–2022) for 163 CRC patients. Information on symptoms of patients were collected from patient files: anemia, anorexia, diarrhea, constipation, abdominal pain, rectal bleeding, and palpable abdominal mass. Tumor locations were classified as right colon, left colon, rectum, and left colon plus rectum. Bivariate analysis was used to analyze the data. Results Of the 163 patients, 98 (58%) were aged e”50 years, 82 (50.3%) were male, and 99 (60.7%) had rectal tumors. The percentage of patients presenting with rectal bleeding was significantly higher in rectal cancers (47.47%) as compared with cancers in the left colon (28.57%) and left colon and rectal (33.33%) cancers (p=0.000). The percentage of patients presenting a palpable abdominal mass was significantly higher in right colon (31.58%) compared with left colon (4.76%) and rectal cancer (1.01%) (p=0.000). ConclusionsTumor location in the right colon is associated with palpable abdominal mass, while rectal location is associated with rectal bleeding in CRC patients. Familiarity with clinical symptoms of CRC could make patients more sensitive to undergo more frequent screening for cancer.

Kata kunci

Jaringan kolaborasi para penulis

13 penulis · 37 tautan kepenulisan bersama · 5 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Syiah Kuala
  • Universitas Islam Negeri Ar-Raniry
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sarah FirdausaUniversitas Syiah Kuala2
Muhammad Ridho Akbar EljatinUniversitas Syiah Kuala2
Muhammad YusufUniversitas Islam Negeri Ar-Raniry1
Subhan Rio PamungkasUniversitas Syiah Kuala1
Sherina Arfi FebriyantiUniversitas Syiah Kuala1
Zulfitri ZulfitriUniversitas Syiah Kuala1
Zulfa ZahraUniversitas Syiah Kuala1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Relationship between presenting symptoms and tumor location  in colorectal cancer patients</dc:title>
	<dc:creator xml:lang="en">Ismida, Fitri Dewi</dc:creator>
	<dc:creator xml:lang="en">Maghfirah, Desi</dc:creator>
	<dc:creator xml:lang="en">Salam, Nurbahri L </dc:creator>
	<dc:creator xml:lang="en">Yusuf, Fauzi </dc:creator>
	<dc:creator xml:lang="en">Mulia, Vera Dewi</dc:creator>
	<dc:creator xml:lang="en">Purnomo, Avisena Gatot</dc:creator>
	<dc:subject xml:lang="en">Tumor location</dc:subject>
	<dc:subject xml:lang="en">symptoms</dc:subject>
	<dc:subject xml:lang="en">rectal bleeding</dc:subject>
	<dc:subject xml:lang="en">palpable abdominal mass</dc:subject>
	<dc:subject xml:lang="en">colorectal cancer</dc:subject>
	<dc:description xml:lang="en">BackgroundColorectal cancer (CRC) often shows symptoms at an advanced stage, causing delayed diagnosis and poorer prognosis. Initial symptoms, or chief complaints, are usually identified through patient history and can vary based on tumor location. This can help in establishing a diagnosis. This study aimed to determine the relationship between presenting symptoms and tumor location in CRC patients at Zainoel Abidin Regional General Hospital, Banda Aceh.
Methods This cross-sectional study was conducted using secondary data from medical records (2019–2022) for 163 CRC patients. Information on symptoms of patients were collected from patient files: anemia, anorexia, diarrhea, constipation, abdominal pain, rectal bleeding, and palpable abdominal mass. Tumor locations were classified as right colon, left colon, rectum, and left colon plus rectum. Bivariate analysis was used to analyze the data.
Results Of the 163 patients, 98 (58%) were aged e”50 years, 82 (50.3%) were male, and 99 (60.7%) had rectal tumors. The percentage of patients presenting with rectal bleeding was significantly higher in rectal cancers (47.47%) as compared with cancers in the left colon (28.57%) and left colon and rectal (33.33%) cancers (p=0.000). The percentage of patients presenting a palpable abdominal mass was significantly higher in right colon (31.58%) compared with left colon (4.76%) and rectal cancer (1.01%) (p=0.000).
ConclusionsTumor location in the right colon is associated with palpable abdominal mass, while rectal location is associated with rectal bleeding in CRC patients. Familiarity with clinical symptoms of CRC could make patients more sensitive to undergo more frequent screening for cancer.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2024-12-09</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/1600</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2024.v43.321-328</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 43 No. 3 (2024); 321-328</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/1600/803</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Fitri Dewi Ismida, Desi Maghfirah, Nurbahri L  Salam, Fauzi  Yusuf, Vera Dewi Mulia, Avisena Gatot Purnomo</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>